Featured Articles

  1. A Supply-Chain Woman Of Iran 9/23/2024

    Arezou Mehrabi has a spellbinding supply-chain case study. It transpired, of all places, in Iran. It includes major challenges in outsourcing manufacturing to a partner CDMO for a top-ten pharma (Sanofi, to be exact). Our protagonist is a woman who took leadership within a male-dominated workplace, country, and entire region. 

  2. Thriving On Ambiguity: What I've Learned Leading Rare Disease Teams 9/19/2024

    Melissa Leichter, a Novo Nordisk executive, describes the distinct skills and mindset needed to succeed in bringing rare disease treatments to market.

  3. Know Your Customer: Strategic Considerations for AI-Powered Provider Segmentation 9/16/2024

    Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio products. Executives at Charles River Associates offer examples of how A.I. can be used to get closer to provider customers.

  4. Improving The Clinical Trial Ecosystem: A Call To Stakeholder Alignment 9/9/2024

    Biopharmaceutical companies must address the frictions and challenges that have quietly infiltrated the drug development ecosystem and root them out, planting instead a new spirit of partnership and collaboration.

  5. 'Explainambiguity:' When What You Think Is Not What You Get 9/6/2024

    As AI integration increases across biopharmaceutical R&D functions, understanding model ambiguities with respect to AI explainability becomes increasingly important.

  6. AI Is A Tool — Not A Replacement — For Human Innovation In Drug Discovery 9/4/2024

    This attorney provides practical advice. Can artificial intelligence (AI) make drug discovery easier? Yes! Will we lose the human component essential to the innovation culture? No.

  7. A Systems Approach To Parkinson's Disease 8/30/2024

    New research into Parkinson's disease is strengthening the connection between an unhealthy gut and brain disorders.

  8. A Vision For Inclusion: Designing Trials That Benefit Visually Impaired Patients 8/30/2024

    Ocugen CMO Huma Qamar, MD, MPH, CMI contends that whether targeting vision-related conditions or other medical needs, sponsors must design trials that ensure vision-impaired patients are included.

  9. 'Doers, not Leaders': How Women Can Overcome A Common Workplace Struggle 8/20/2024

    Three key strategies can help women working in the biopharmaceutical industry shift from being seen as 'doers' to being recognized as 'leaders': vision, networking, and self-advocacy, writes Mary Beth Sandin.

  10. This Takeda Official Thinks Pharma 4.0 Won't Be Optional Much Longer 8/14/2024

    Advanced technology like automation was once seen only as a competitive advantage. That viewpoint is shifting amid greater reliance on digital technology.